2025
SJR Q2
JCR Q3 · 2,8
54 matched articles
SCIE
Journal detail
Tissue Engineering - Part A
- Publisher
- Mary Ann Liebert Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
193733411937335X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,704
- Quartile Q2
- H-Index 142
- Cites/doc 3,3
- Docs (3y) 213
- Cites (3y) 705
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,8
- 5Y JIF 3,4
- JCI 0,52
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biochemistry Q2
- Bioengineering Q2
- Biomaterials Q2
- Biomedical Engineering Q2
Areas
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,704 | 2,8 | 3,4 | 0,52 | Q3 | 142 |
| 2024 | Q2 | Q3 | 0,709 | 2,9 | 3,3 | 0,58 | Q3 | 139 |
| 2023 | Q2 | Q2 | 0,825 | 3,5 | 4,7 | 0,71 | Q2 | 139 |
| 2022 | Q2 | Q2 | 0,74 | 4,1 | 4,2 | 0,71 | Q2 | 139 |
| 2021 | Q2 | Q2 | 0,726 | 4,1 | 4,5 | 0,71 | Q2 | 139 |
| 2020 | Q2 | Q2 | 0,964 | 3,8 | 4,3 | 0,91 | Q2 | 139 |
| 2019 | Q1 | Q1 | 1,028 | 3,8 | 3,5 | 0,92 | Q2 | 139 |
| 2018 | — | Q2 | — | 3,6 | 3,7 | 0,89 | Q2 | — |
| 2017 | Q1 | — | 1,159 | — | — | — | — | 139 |
| 2016 | Q1 | — | 1,24 | — | — | — | — | 139 |
| 2015 | Q1 | — | 1,536 | — | — | — | — | 139 |
| 2014 | Q1 | — | 1,624 | — | — | — | — | 139 |
| 2013 | Q1 | — | 1,711 | — | — | — | — | 139 |
| 2012 | Q1 | — | 2,029 | — | — | — | — | 139 |
| 2011 | Q1 | — | 1,863 | — | — | — | — | 139 |
| 2010 | Q1 | — | 1,344 | — | — | — | — | 139 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CELL BIOLOGY | SCIE | Q3 | Q3 | 143/207 |
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 23/32 |
| 2025 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 75/130 |
| 2025 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q4 | Q3 | 44/58 |
| 2024 | CELL BIOLOGY | SCIE | Q3 | Q3 | 127/204 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 21/32 |
| 2024 | ENGINEERING, BIOMEDICAL | SCIE | Q3 | Q3 | 64/124 |
| 2024 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q3 | 40/55 |
| 2023 | CELL BIOLOGY | SCIE | Q3 | Q2 | 110/205 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 17/31 |
| 2023 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 49/123 |
| 2023 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q3 | 30/53 |
| 2022 | CELL BIOLOGY | SCIE | Q3 | Q2 | 100/191 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 15/29 |
| 2022 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 41/96 |
| 2022 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q3 | 23/45 |
| 2021 | CELL BIOLOGY | SCIE | Q3 | Q2 | 120/195 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q3 | 20/29 |
| 2021 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 47/98 |
| 2021 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q3 | 25/45 |
| 2020 | CELL BIOLOGY | SCIE | Q3 | Q2 | 125/195 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q3 | Q2 | 19/29 |
| 2020 | ENGINEERING, BIOMEDICAL | SCIE | Q2 | Q2 | 35/89 |
| 2020 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q3 | Q2 | 24/41 |
| 2019 | CELL BIOLOGY | SCIE | Q2 | Q2 | 91/195 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q3 | 14/29 |
| 2019 | ENGINEERING, BIOMEDICAL | SCIE | Q1 | Q2 | 19/87 |
| 2019 | MATERIALS SCIENCE, BIOMATERIALS | SCIE | Q2 | Q2 | 15/38 |
| 2018 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q2 | — | 43/162 |
| 2018 | CELL BIOLOGY | SCIE | Q2 | Q2 | 90/193 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q3 | 13/26 |